LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset - HMS LINCS Database

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

|<
<<
Previous
Page 37 of 66
Next
>>
>
901 to 925 of 1647 records
per page:

Small Molecule	barcode	cell_count	frac_dead	corpse_count	cell_count_dead	row	column	agent	concentration	role	timepoint	replicate	cell_line	dead_count	fraction_dead	cell_count__time0	dead_count__time0	cell_count__ctrl	dead_count__ctrl	fraction_dead__ctrl	increase_fraction_dead	GRvalue
Taxol	180619_MC_10	182	1.1074	302	234	3	19	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_1	536	0.7465	635.9	71.1	15071	356.7	0.0231	0.72344	-0.2396
Taxol	180619_MC_10	211	1.0693	193	239	11	7	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_2	432	0.6719	635.9	71.1	15071	356.7	0.0231	0.64878	-0.2146
Taxol	180619_MC_10	359	0.7662	150	240	12	16	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_3	390	0.5207	635.9	71.1	15071	356.7	0.0231	0.49762	-0.1177
Taxol	180619_MC_11	262	0.8493	196	193	4	16	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_4	389	0.5975	635.9	71.1	15071	356.7	0.0231	0.57447	-0.1765
Taxol	180619_MC_11	232	1.1323	282	300	9	10	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_5	582	0.7150	635.9	71.1	15071	356.7	0.0231	0.69191	-0.1981
Taxol	180619_MC_11	277	0.8565	169	213	10	14	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_6	382	0.5797	635.9	71.1	15071	356.7	0.0231	0.55659	-0.1664
Taxol	180619_MC_12	252	1.0820	309	298	4	20	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_7	607	0.7066	635.9	71.1	15071	356.7	0.0231	0.68356	-0.1835
Taxol	180619_MC_12	218	1.1855	348	323	7	8	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_8	671	0.7548	635.9	71.1	15071	356.7	0.0231	0.73171	-0.2090
Taxol	180619_MC_12	264	1.0333	337	284	11	18	Paclitaxel	0.031603332	treatment	72	2	MCF10A-GM_9	621	0.7017	635.9	71.1	15071	356.7	0.0231	0.67862	-0.1751
Taxol	180619_MC_10	219	1.1072	294	274	4	14	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_1	568	0.7217	635.9	71.1	15071	356.7	0.0231	0.69865	-0.2082
Taxol	180619_MC_10	223	1.0587	339	256	5	14	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_2	595	0.7274	635.9	71.1	15071	356.7	0.0231	0.70431	-0.2050
Taxol	180619_MC_10	192	1.0669	152	215	6	7	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_3	367	0.6565	635.9	71.1	15071	356.7	0.0231	0.63346	-0.2307
Taxol	180619_MC_11	222	1.0303	240	236	10	22	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_4	476	0.6819	635.9	71.1	15071	356.7	0.0231	0.65887	-0.2058
Taxol	180619_MC_11	185	1.0670	248	214	11	17	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_5	462	0.7141	635.9	71.1	15071	356.7	0.0231	0.69099	-0.2369
Taxol	180619_MC_11	192	1.1138	265	244	14	20	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_3	509	0.7261	635.9	71.1	15071	356.7	0.0231	0.70303	-0.2307
Taxol	180619_MC_12	232	1.0296	377	250	3	20	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_6	627	0.7299	635.9	71.1	15071	356.7	0.0231	0.70684	-0.1981
Taxol	180619_MC_12	170	1.2075	447	298	9	13	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_7	745	0.8142	635.9	71.1	15071	356.7	0.0231	0.79113	-0.2509
Taxol	180619_MC_12	153	1.2797	344	292	14	5	Paclitaxel	0.099799981	treatment	72	2	MCF10A-GM_8	636	0.8061	635.9	71.1	15071	356.7	0.0231	0.78301	-0.2680
Taxol	180619_MC_10	172	1.0344	177	184	4	18	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_1	361	0.6773	635.9	71.1	15071	356.7	0.0231	0.65422	-0.2490
Taxol	180619_MC_10	204	1.0740	269	239	7	19	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_2	508	0.7135	635.9	71.1	15071	356.7	0.0231	0.69041	-0.2204
Taxol	180619_MC_10	142	1.2687	260	250	8	3	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_3	510	0.7822	635.9	71.1	15071	356.7	0.0231	0.75913	-0.2798
Taxol	180619_MC_11	215	0.9824	183	208	4	12	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_4	391	0.6452	635.9	71.1	15071	356.7	0.0231	0.62214	-0.2114
Taxol	180619_MC_11	192	1.1699	279	272	11	15	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_5	551	0.7416	635.9	71.1	15071	356.7	0.0231	0.71851	-0.2307
Taxol	180619_MC_11	174	1.1342	288	236	13	9	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_6	524	0.7507	635.9	71.1	15071	356.7	0.0231	0.72764	-0.2471
Taxol	180619_MC_12	190	1.0164	298	198	7	21	Paclitaxel	0.312706472	treatment	72	2	MCF10A-GM_7	496	0.7230	635.9	71.1	15071	356.7	0.0231	0.69996	-0.2324

|<
<<
Previous
Page 37 of 66
Next
>>
>
901 to 925 of 1647 records
per page:

HMS LINCS Project

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)